APO Research
Talk to an analyst

APO RESEARCH · REPORT

Inhaler Devices for Respiratory Medicines

Compare research editions
View pricing & licenses

Selected research

Industry Research

Inhaler Devices for Respiratory Medicines Industry Research Report 2026

28 December 2025133 pages

Choose your research edition.

Industry ResearchInhaler Devices for Respiratory Medicines Industry Research Report 2026133 pages · $2,950 USDIndustry Growth & TrendsGlobal Inhaler Devices for Respiratory Medicines Industry Growth and Trends Forecast to 2032119 pages · $3,450 USDMarket StructureGlobal Inhaler Devices for Respiratory Medicines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Inhaler Devices for Respiratory Medicines Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Inhaler Devices for Respiratory Medicines Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Inhaler Devices for Respiratory Medicines market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Inhaler Devices for Respiratory Medicines is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Inhaler Devices for Respiratory Medicines is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Inhaler Devices for Respiratory Medicines is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Inhaler Devices for Respiratory Medicines include Novartis, Viatris, Mylan, AstraZeneca, Vectura, Teva Pharmaceutical Industries, PARI International, OMRON and Monaghan Medical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Inhaler Devices for Respiratory Medicines market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Inhaler Devices for Respiratory Medicines Market by Company

Novartis

Viatris

Mylan

AstraZeneca

Vectura

Teva Pharmaceutical Industries

PARI International

OMRON

Monaghan Medical

Koninklijke Philips

H&T Presspart

GlaxoSmithKline (GSK)

Chiesi Farmaceutici

Boehringer Ingelheim

AptarGroup

Inhaler Devices for Respiratory Medicines Segment by Type

Metered- dose Inhalers

Dry-powder Inhalers

Nebulizers

Inhaler Devices for Respiratory Medicines Segment by Application

Chronic Obstructive Pulmonary Disease (COPD)

Cystic Fibrosis (CF)

Idiopathic Pulmonary Fibrosis (IPF)

Asthma

Others

Inhaler Devices for Respiratory Medicines Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Inhaler Devices for Respiratory Medicines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Inhaler Devices for Respiratory Medicines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Inhaler Devices for Respiratory Medicines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Inhaler Devices for Respiratory Medicines manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Inhaler Devices for Respiratory Medicines by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Inhaler Devices for Respiratory Medicines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Inhaler Devices for Respiratory Medicines Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Inhaler Devices for Respiratory Medicines Sales (K Units) of Manufacturers (2021-2026) Table 7. Global Inhaler Devices for Respiratory Medicines Sales Market Share by Manufacturers (2021-2026) Table 8. Global Inhaler Devices for Respiratory Medicines Revenue of Manufacturers (2021-2026) Table 9. Global Inhaler Devices for Respiratory Medicines Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Inhaler Devices for Respiratory Medicines Average Price (US$/Unit) of Manufacturers (2021-2026) Table 11. Global Inhaler Devices for Respiratory Medicines Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Inhaler Devices for Respiratory Medicines, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Inhaler Devices for Respiratory Medicines, Product Type & Application Table 14. Global Inhaler Devices for Respiratory Medicines Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Inhaler Devices for Respiratory Medicines by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Novartis Company Information Table 19. Novartis Business Overview Table 20. Novartis Inhaler Devices for Respiratory Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 21. Novartis Inhaler Devices for Respiratory Medicines Product Portfolio Table 22. Novartis Recent Developments Table 23. Viatris Company Information Table 24. Viatris Business Overview Table 25. Viatris Inhaler Devices for Respiratory Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 26. Viatris Inhaler Devices for Respiratory Medicines Product Portfolio Table 27. Viatris Recent Developments Table 28. Mylan Company Information Table 29. Mylan Business Overview Table 30. Mylan Inhaler Devices for Respiratory Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 31. Mylan Inhaler Devices for Respiratory Medicines Product Portfolio Table 32. Mylan Recent Developments Table 33. AstraZeneca Company Information Table 34. AstraZeneca Business Overview Table 35. AstraZeneca Inhaler Devices for Respiratory Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 36. AstraZeneca Inhaler Devices for Respiratory Medicines Product Portfolio Table 37. AstraZeneca Recent Developments Table 38. Vectura Company Information Table 39. Vectura Business Overview Table 40. Vectura Inhaler Devices for Respiratory Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 41. Vectura Inhaler Devices for Respiratory Medicines Product Portfolio Table 42. Vectura Recent Developments Table 43. Teva Pharmaceutical Industries Company Information Table 44. Teva Pharmaceutical Industries Business Overview Table 45. Teva Pharmaceutical Industries Inhaler Devices for Respiratory Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Teva Pharmaceutical Industries Inhaler Devices for Respiratory Medicines Product Portfolio Table 47. Teva Pharmaceutical Industries Recent Developments Table 48. PARI International Company Information Table 49. PARI International Business Overview Table 50. PARI International Inhaler Devices for Respiratory Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 51. PARI International Inhaler Devices for Respiratory Medicines Product Portfolio Table 52. PARI International Recent Developments Table 53. OMRON Company Information Table 54. OMRON Business Overview Table 55. OMRON Inhaler Devices for Respiratory Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 56. OMRON Inhaler Devices for Respiratory Medicines Product Portfolio Table 57. OMRON Recent Developments Table 58. Monaghan Medical Company Information Table 59. Monaghan Medical Business Overview Table 60. Monaghan Medical Inhaler Devices for Respiratory Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. Monaghan Medical Inhaler Devices for Respiratory Medicines Product Portfolio Table 62. Monaghan Medical Recent Developments Table 63. Koninklijke Philips Company Information Table 64. Koninklijke Philips Business Overview Table 65. Koninklijke Philips Inhaler Devices for Respiratory Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Koninklijke Philips Inhaler Devices for Respiratory Medicines Product Portfolio Table 67. Koninklijke Philips Recent Developments Table 68. H&T Presspart Company Information Table 69. H&T Presspart Business Overview Table 70. H&T Presspart Inhaler Devices for Respiratory Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. H&T Presspart Inhaler Devices for Respiratory Medicines Product Portfolio Table 72. H&T Presspart Recent Developments Table 73. GlaxoSmithKline (GSK) Company Information Table 74. GlaxoSmithKline (GSK) Business Overview Table 75. GlaxoSmithKline (GSK) Inhaler Devices for Respiratory Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. GlaxoSmithKline (GSK) Inhaler Devices for Respiratory Medicines Product Portfolio Table 77. GlaxoSmithKline (GSK) Recent Developments Table 78. Chiesi Farmaceutici Company Information Table 79. Chiesi Farmaceutici Business Overview Table 80. Chiesi Farmaceutici Inhaler Devices for Respiratory Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Chiesi Farmaceutici Inhaler Devices for Respiratory Medicines Product Portfolio Table 82. Chiesi Farmaceutici Recent Developments Table 83. Boehringer Ingelheim Company Information Table 84. Boehringer Ingelheim Business Overview Table 85. Boehringer Ingelheim Inhaler Devices for Respiratory Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Boehringer Ingelheim Inhaler Devices for Respiratory Medicines Product Portfolio Table 87. Boehringer Ingelheim Recent Developments Table 88. AptarGroup Company Information Table 89. AptarGroup Business Overview Table 90. AptarGroup Inhaler Devices for Respiratory Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. AptarGroup Inhaler Devices for Respiratory Medicines Product Portfolio Table 92. AptarGroup Recent Developments Table 93. Global Inhaler Devices for Respiratory Medicines Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 94. Global Inhaler Devices for Respiratory Medicines Sales by Region (2021-2026) & (K Units) Table 95. Global Inhaler Devices for Respiratory Medicines Sales Market Share by Region (2021-2026) Table 96. Global Inhaler Devices for Respiratory Medicines Sales by Region (2027-2032) & (K Units) Table 97. Global Inhaler Devices for Respiratory Medicines Sales Market Share by Region (2027-2032) Table 98. Global Inhaler Devices for Respiratory Medicines Revenue by Region (2021-2026) & (US$ Million) Table 99. Global Inhaler Devices for Respiratory Medicines Revenue Market Share by Region (2021-2026) Table 100. Global Inhaler Devices for Respiratory Medicines Revenue by Region (2027-2032) & (US$ Million) Table 101. Global Inhaler Devices for Respiratory Medicines Revenue Market Share by Region (2027-2032) Table 102. North America Inhaler Devices for Respiratory Medicines Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 103. North America Inhaler Devices for Respiratory Medicines Sales by Country (2021-2026) & (K Units) Table 104. North America Inhaler Devices for Respiratory Medicines Sales by Country (2027-2032) & (K Units) Table 105. North America Inhaler Devices for Respiratory Medicines Revenue by Country (2021-2026) & (US$ Million) Table 106. North America Inhaler Devices for Respiratory Medicines Revenue by Country (2027-2032) & (US$ Million) Table 107. Europe Inhaler Devices for Respiratory Medicines Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 108. Europe Inhaler Devices for Respiratory Medicines Sales by Country (2021-2026) & (K Units) Table 109. Europe Inhaler Devices for Respiratory Medicines Sales by Country (2027-2032) & (K Units) Table 110. Europe Inhaler Devices for Respiratory Medicines Revenue by Country (2021-2026) & (US$ Million) Table 111. Europe Inhaler Devices for Respiratory Medicines Revenue by Country (2027-2032) & (US$ Million) Table 112. Asia Pacific Inhaler Devices for Respiratory Medicines Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 113. Asia Pacific Inhaler Devices for Respiratory Medicines Sales by Country (2021-2026) & (K Units) Table 114. Asia Pacific Inhaler Devices for Respiratory Medicines Sales by Country (2027-2032) & (K Units) Table 115. Asia Pacific Inhaler Devices for Respiratory Medicines Revenue by Country (2021-2026) & (US$ Million) Table 116. Asia Pacific Inhaler Devices for Respiratory Medicines Revenue by Country (2027-2032) & (US$ Million) Table 117. South America Inhaler Devices for Respiratory Medicines Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 118. South America Inhaler Devices for Respiratory Medicines Sales by Country (2021-2026) & (K Units) Table 119. South America Inhaler Devices for Respiratory Medicines Sales by Country (2027-2032) & (K Units) Table 120. South America Inhaler Devices for Respiratory Medicines Revenue by Country (2021-2026) & (US$ Million) Table 121. South America Inhaler Devices for Respiratory Medicines Revenue by Country (2027-2032) & (US$ Million) Table 122. Middle East and Africa Inhaler Devices for Respiratory Medicines Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 123. Middle East and Africa Inhaler Devices for Respiratory Medicines Sales by Country (2021-2026) & (K Units) Table 124. Middle East and Africa Inhaler Devices for Respiratory Medicines Sales by Country (2027-2032) & (K Units) Table 125. Middle East and Africa Inhaler Devices for Respiratory Medicines Revenue by Country (2021-2026) & (US$ Million) Table 126. Middle East and Africa Inhaler Devices for Respiratory Medicines Revenue by Country (2027-2032) & (US$ Million) Table 127. Global Inhaler Devices for Respiratory Medicines Sales by Type (2021-2026) & (K Units) Table 128. Global Inhaler Devices for Respiratory Medicines Sales by Type (2027-2032) & (K Units) Table 129. Global Inhaler Devices for Respiratory Medicines Sales Market Share by Type (2021-2026) Table 130. Global Inhaler Devices for Respiratory Medicines Sales Market Share by Type (2027-2032) Table 131. Global Inhaler Devices for Respiratory Medicines Revenue by Type (2021-2026) & (US$ Million) Table 132. Global Inhaler Devices for Respiratory Medicines Revenue by Type (2027-2032) & (US$ Million) Table 133. Global Inhaler Devices for Respiratory Medicines Revenue Market Share by Type (2021-2026) Table 134. Global Inhaler Devices for Respiratory Medicines Revenue Market Share by Type (2027-2032) Table 135. Global Inhaler Devices for Respiratory Medicines Price by Type (2021-2026) & (US$/Unit) Table 136. Global Inhaler Devices for Respiratory Medicines Price by Type (2027-2032) & (US$/Unit) Table 137. Global Inhaler Devices for Respiratory Medicines Sales by Application (2021-2026) & (K Units) Table 138. Global Inhaler Devices for Respiratory Medicines Sales by Application (2027-2032) & (K Units) Table 139. Global Inhaler Devices for Respiratory Medicines Sales Market Share by Application (2021-2026) Table 140. Global Inhaler Devices for Respiratory Medicines Sales Market Share by Application (2027-2032) Table 141. Global Inhaler Devices for Respiratory Medicines Revenue by Application (2021-2026) & (US$ Million) Table 142. Global Inhaler Devices for Respiratory Medicines Revenue by Application (2027-2032) & (US$ Million) Table 143. Global Inhaler Devices for Respiratory Medicines Revenue Market Share by Application (2021-2026) Table 144. Global Inhaler Devices for Respiratory Medicines Revenue Market Share by Application (2027-2032) Table 145. Global Inhaler Devices for Respiratory Medicines Price by Application (2021-2026) & (US$/Unit) Table 146. Global Inhaler Devices for Respiratory Medicines Price by Application (2027-2032) & (US$/Unit) Table 147. Key Raw Materials Table 148. Raw Materials Key Suppliers Table 149. Inhaler Devices for Respiratory Medicines Distributors List Table 150. Inhaler Devices for Respiratory Medicines Customers List Table 151. Inhaler Devices for Respiratory Medicines Industry Trends Table 152. Inhaler Devices for Respiratory Medicines Industry Drivers Table 153. Inhaler Devices for Respiratory Medicines Industry Restraints Table 154. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Inhaler Devices for Respiratory Medicines Product Image Figure 5. Global Inhaler Devices for Respiratory Medicines Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Inhaler Devices for Respiratory Medicines Market Size (2021-2032) & (US$ Million) Figure 7. Global Inhaler Devices for Respiratory Medicines Sales (2021-2032) & (K Units) Figure 8. Global Inhaler Devices for Respiratory Medicines Average Price (US$/Unit) & (2021-2032) Figure 9. Metered- dose Inhalers Product Image Figure 10. Dry-powder Inhalers Product Image Figure 11. Nebulizers Product Image Figure 12. Chronic Obstructive Pulmonary Disease (COPD) Product Image Figure 13. Cystic Fibrosis (CF) Product Image Figure 14. Idiopathic Pulmonary Fibrosis (IPF) Product Image Figure 15. Asthma Product Image Figure 16. Others Product Image Figure 17. Global Inhaler Devices for Respiratory Medicines Revenue Share by Manufacturers in 2025 Figure 18. Global Manufacturers of Inhaler Devices for Respiratory Medicines, Manufacturing Sites & Headquarters Figure 19. Global Top 5 and 10 Inhaler Devices for Respiratory Medicines Players Market Share by Revenue in 2025 Figure 20. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 21. Global Inhaler Devices for Respiratory Medicines Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 22. Global Inhaler Devices for Respiratory Medicines Sales by Region in 2025 Figure 23. Global Inhaler Devices for Respiratory Medicines Revenue by Region in 2025 Figure 24. North America Inhaler Devices for Respiratory Medicines Market Size by Country in 2025 Figure 25. North America Inhaler Devices for Respiratory Medicines Sales Market Share by Country (2021-2032) Figure 26. North America Inhaler Devices for Respiratory Medicines Revenue Market Share by Country (2021-2032) Figure 27. United States Inhaler Devices for Respiratory Medicines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 28. Canada Inhaler Devices for Respiratory Medicines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 29. Mexico Inhaler Devices for Respiratory Medicines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 30. Europe Inhaler Devices for Respiratory Medicines Market Size by Country in 2025 Figure 31. Europe Inhaler Devices for Respiratory Medicines Sales Market Share by Country (2021-2032) Figure 32. Europe Inhaler Devices for Respiratory Medicines Revenue Market Share by Country (2021-2032) Figure 33. Germany Inhaler Devices for Respiratory Medicines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. France Inhaler Devices for Respiratory Medicines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. U.K. Inhaler Devices for Respiratory Medicines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Italy Inhaler Devices for Respiratory Medicines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Russia Inhaler Devices for Respiratory Medicines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Spain Inhaler Devices for Respiratory Medicines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Netherlands Inhaler Devices for Respiratory Medicines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Switzerland Inhaler Devices for Respiratory Medicines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. Sweden Inhaler Devices for Respiratory Medicines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 42. Poland Inhaler Devices for Respiratory Medicines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 43. Asia Pacific Inhaler Devices for Respiratory Medicines Market Size by Country in 2025 Figure 44. Asia Pacific Inhaler Devices for Respiratory Medicines Sales Market Share by Country (2021-2032) Figure 45. Asia Pacific Inhaler Devices for Respiratory Medicines Revenue Market Share by Country (2021-2032) Figure 46. China Inhaler Devices for Respiratory Medicines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. Japan Inhaler Devices for Respiratory Medicines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. South Korea Inhaler Devices for Respiratory Medicines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. India Inhaler Devices for Respiratory Medicines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Australia Inhaler Devices for Respiratory Medicines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. Taiwan Inhaler Devices for Respiratory Medicines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 52. Southeast Asia Inhaler Devices for Respiratory Medicines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 53. Southeast Asia Inhaler Devices for Respiratory Medicines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 54. South America Inhaler Devices for Respiratory Medicines Market Size by Country in 2025 Figure 55. South America Inhaler Devices for Respiratory Medicines Sales Market Share by Country (2021-2032) Figure 56. South America Inhaler Devices for Respiratory Medicines Revenue Market Share by Country (2021-2032) Figure 57. Brazil Inhaler Devices for Respiratory Medicines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 58. Argentina Inhaler Devices for Respiratory Medicines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 59. Chile Inhaler Devices for Respiratory Medicines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 60. Colombia Inhaler Devices for Respiratory Medicines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 61. Middle East and Africa Inhaler Devices for Respiratory Medicines Market Size by Country in 2025 Figure 62. Middle East and Africa Inhaler Devices for Respiratory Medicines Sales Market Share by Country (2021-2032) Figure 63. Middle East and Africa Inhaler Devices for Respiratory Medicines Revenue Market Share by Country (2021-2032) Figure 64. Egypt Inhaler Devices for Respiratory Medicines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 65. South Africa Inhaler Devices for Respiratory Medicines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 66. Israel Inhaler Devices for Respiratory Medicines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 67. Türkiye Inhaler Devices for Respiratory Medicines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 68. GCC Countries Inhaler Devices for Respiratory Medicines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 69. Global Inhaler Devices for Respiratory Medicines Sales Market Share by Type (2021-2032) Figure 70. Global Inhaler Devices for Respiratory Medicines Revenue Market Share by Type (2021-2032) Figure 71. Global Inhaler Devices for Respiratory Medicines Price (US$/Unit) by Type (2021-2032) Figure 72. Global Inhaler Devices for Respiratory Medicines Sales Market Share by Application (2021-2032) Figure 73. Global Inhaler Devices for Respiratory Medicines Revenue Market Share by Application (2021-2032) Figure 74. Global Inhaler Devices for Respiratory Medicines Price (US$/Unit) by Application (2021-2032) Figure 75. Inhaler Devices for Respiratory Medicines Value Chain Figure 76. Inhaler Devices for Respiratory Medicines Production Mode & Process Figure 77. Direct Comparison with Distribution Share Figure 78. Distributors Profiles Figure 79. Inhaler Devices for Respiratory Medicines Industry Opportunities and Challenges

Scope & coverage.

Types
  • Metered- dose Inhalers
  • Dry-powder Inhalers
  • Nebulizers
Applications
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Cystic Fibrosis (CF)
  • Idiopathic Pulmonary Fibrosis (IPF)
  • Asthma
  • Others
Companies covered
  • Novartis
  • Viatris
  • Mylan
  • AstraZeneca
  • Vectura
  • Teva Pharmaceutical Industries
  • PARI International
  • OMRON
  • Monaghan Medical
  • Koninklijke Philips
  • H&T Presspart
  • GlaxoSmithKline (GSK)
  • Chiesi Farmaceutici
  • Boehringer Ingelheim
  • AptarGroup

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Inhaler Devices for Respiratory Medicines Market Size (2021-2032)
  4. 2.2.2 Global Inhaler Devices for Respiratory Medicines Sales (2021-2032)
  5. 2.2.3 Global Inhaler Devices for Respiratory Medicines Market Average Price (2021-2032)
  6. 2.3 Inhaler Devices for Respiratory Medicines by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Metered- dose Inhalers
  9. 2.3.3 Dry-powder Inhalers
  10. 2.3.4 Nebulizers
  11. 2.4 Inhaler Devices for Respiratory Medicines by Application
  12. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  13. 2.4.2 Chronic Obstructive Pulmonary Disease (COPD)
  14. 2.4.3 Cystic Fibrosis (CF)
  15. 2.4.4 Idiopathic Pulmonary Fibrosis (IPF)
  16. 2.4.5 Asthma
  17. 2.4.6 Others
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Inhaler Devices for Respiratory Medicines Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Inhaler Devices for Respiratory Medicines Sales (K Units) of Manufacturers (2021-2026)
  3. 3.3 Global Inhaler Devices for Respiratory Medicines Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Inhaler Devices for Respiratory Medicines Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Inhaler Devices for Respiratory Medicines Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Inhaler Devices for Respiratory Medicines, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Inhaler Devices for Respiratory Medicines, Product Type & Application
  8. 3.8 Global Manufacturers of Inhaler Devices for Respiratory Medicines, Established Date
  9. 3.9 Global Inhaler Devices for Respiratory Medicines Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Novartis
  2. 4.1.1 Novartis Company Information
  3. 4.1.2 Novartis Business Overview
  4. 4.1.3 Novartis Inhaler Devices for Respiratory Medicines Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Novartis Inhaler Devices for Respiratory Medicines Product Portfolio
  6. 4.1.5 Novartis Recent Developments
  7. 4.2 Viatris
  8. 4.2.1 Viatris Company Information
  9. 4.2.2 Viatris Business Overview
  10. 4.2.3 Viatris Inhaler Devices for Respiratory Medicines Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Viatris Inhaler Devices for Respiratory Medicines Product Portfolio
  12. 4.2.5 Viatris Recent Developments
  13. 4.3 Mylan
  14. 4.3.1 Mylan Company Information
  15. 4.3.2 Mylan Business Overview
  16. 4.3.3 Mylan Inhaler Devices for Respiratory Medicines Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Mylan Inhaler Devices for Respiratory Medicines Product Portfolio
  18. 4.3.5 Mylan Recent Developments
  19. 4.4 AstraZeneca
  20. 4.4.1 AstraZeneca Company Information
  21. 4.4.2 AstraZeneca Business Overview
  22. 4.4.3 AstraZeneca Inhaler Devices for Respiratory Medicines Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 AstraZeneca Inhaler Devices for Respiratory Medicines Product Portfolio
  24. 4.4.5 AstraZeneca Recent Developments
  25. 4.5 Vectura
  26. 4.5.1 Vectura Company Information
  27. 4.5.2 Vectura Business Overview
  28. 4.5.3 Vectura Inhaler Devices for Respiratory Medicines Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Vectura Inhaler Devices for Respiratory Medicines Product Portfolio
  30. 4.5.5 Vectura Recent Developments
  31. 4.6 Teva Pharmaceutical Industries
  32. 4.6.1 Teva Pharmaceutical Industries Company Information
  33. 4.6.2 Teva Pharmaceutical Industries Business Overview
  34. 4.6.3 Teva Pharmaceutical Industries Inhaler Devices for Respiratory Medicines Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Teva Pharmaceutical Industries Inhaler Devices for Respiratory Medicines Product Portfolio
  36. 4.6.5 Teva Pharmaceutical Industries Recent Developments
  37. 4.7 PARI International
  38. 4.7.1 PARI International Company Information
  39. 4.7.2 PARI International Business Overview
  40. 4.7.3 PARI International Inhaler Devices for Respiratory Medicines Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 PARI International Inhaler Devices for Respiratory Medicines Product Portfolio
  42. 4.7.5 PARI International Recent Developments
  43. 4.8 OMRON
  44. 4.8.1 OMRON Company Information
  45. 4.8.2 OMRON Business Overview
  46. 4.8.3 OMRON Inhaler Devices for Respiratory Medicines Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 OMRON Inhaler Devices for Respiratory Medicines Product Portfolio
  48. 4.8.5 OMRON Recent Developments
  49. 4.9 Monaghan Medical
  50. 4.9.1 Monaghan Medical Company Information
  51. 4.9.2 Monaghan Medical Business Overview
  52. 4.9.3 Monaghan Medical Inhaler Devices for Respiratory Medicines Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Monaghan Medical Inhaler Devices for Respiratory Medicines Product Portfolio
  54. 4.9.5 Monaghan Medical Recent Developments
  55. 4.10 Koninklijke Philips
  56. 4.10.1 Koninklijke Philips Company Information
  57. 4.10.2 Koninklijke Philips Business Overview
  58. 4.10.3 Koninklijke Philips Inhaler Devices for Respiratory Medicines Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Koninklijke Philips Inhaler Devices for Respiratory Medicines Product Portfolio
  60. 4.10.5 Koninklijke Philips Recent Developments
  61. 4.11 H&T Presspart
  62. 4.11.1 H&T Presspart Company Information
  63. 4.11.2 H&T Presspart Business Overview
  64. 4.11.3 H&T Presspart Inhaler Devices for Respiratory Medicines Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 H&T Presspart Inhaler Devices for Respiratory Medicines Product Portfolio
  66. 4.11.5 H&T Presspart Recent Developments
  67. 4.12 GlaxoSmithKline (GSK)
  68. 4.12.1 GlaxoSmithKline (GSK) Company Information
  69. 4.12.2 GlaxoSmithKline (GSK) Business Overview
  70. 4.12.3 GlaxoSmithKline (GSK) Inhaler Devices for Respiratory Medicines Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 GlaxoSmithKline (GSK) Inhaler Devices for Respiratory Medicines Product Portfolio
  72. 4.12.5 GlaxoSmithKline (GSK) Recent Developments
  73. 4.13 Chiesi Farmaceutici
  74. 4.13.1 Chiesi Farmaceutici Company Information
  75. 4.13.2 Chiesi Farmaceutici Business Overview
  76. 4.13.3 Chiesi Farmaceutici Inhaler Devices for Respiratory Medicines Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 Chiesi Farmaceutici Inhaler Devices for Respiratory Medicines Product Portfolio
  78. 4.13.5 Chiesi Farmaceutici Recent Developments
  79. 4.14 Boehringer Ingelheim
  80. 4.14.1 Boehringer Ingelheim Company Information
  81. 4.14.2 Boehringer Ingelheim Business Overview
  82. 4.14.3 Boehringer Ingelheim Inhaler Devices for Respiratory Medicines Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 Boehringer Ingelheim Inhaler Devices for Respiratory Medicines Product Portfolio
  84. 4.14.5 Boehringer Ingelheim Recent Developments
  85. 4.15 AptarGroup
  86. 4.15.1 AptarGroup Company Information
  87. 4.15.2 AptarGroup Business Overview
  88. 4.15.3 AptarGroup Inhaler Devices for Respiratory Medicines Sales, Revenue and Gross Margin (2021-2026)
  89. 4.15.4 AptarGroup Inhaler Devices for Respiratory Medicines Product Portfolio
  90. 4.15.5 AptarGroup Recent Developments
5 Global Inhaler Devices for Respiratory Medicines Market Scenario by Region
  1. 5.1 Global Inhaler Devices for Respiratory Medicines Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Inhaler Devices for Respiratory Medicines Sales by Region: 2021-2032
  3. 5.2.1 Global Inhaler Devices for Respiratory Medicines Sales by Region: 2021-2026
  4. 5.2.2 Global Inhaler Devices for Respiratory Medicines Sales by Region: 2027-2032
  5. 5.3 Global Inhaler Devices for Respiratory Medicines Revenue by Region: 2021-2032
  6. 5.3.1 Global Inhaler Devices for Respiratory Medicines Revenue by Region: 2021-2026
  7. 5.3.2 Global Inhaler Devices for Respiratory Medicines Revenue by Region: 2027-2032
  8. 5.4 North America Inhaler Devices for Respiratory Medicines Market Facts & Figures by Country
  9. 5.4.1 North America Inhaler Devices for Respiratory Medicines Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Inhaler Devices for Respiratory Medicines Sales by Country (2021-2032)
  11. 5.4.3 North America Inhaler Devices for Respiratory Medicines Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Inhaler Devices for Respiratory Medicines Market Facts & Figures by Country
  16. 5.5.1 Europe Inhaler Devices for Respiratory Medicines Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Inhaler Devices for Respiratory Medicines Sales by Country (2021-2032)
  18. 5.5.3 Europe Inhaler Devices for Respiratory Medicines Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Inhaler Devices for Respiratory Medicines Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Inhaler Devices for Respiratory Medicines Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Inhaler Devices for Respiratory Medicines Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Inhaler Devices for Respiratory Medicines Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Inhaler Devices for Respiratory Medicines Market Facts & Figures by Country
  41. 5.7.1 South America Inhaler Devices for Respiratory Medicines Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Inhaler Devices for Respiratory Medicines Sales by Country (2021-2032)
  43. 5.7.3 South America Inhaler Devices for Respiratory Medicines Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.7.7 Colombia
  48. 5.8 Middle East and Africa Inhaler Devices for Respiratory Medicines Market Facts & Figures by Country
  49. 5.8.1 Middle East and Africa Inhaler Devices for Respiratory Medicines Market Size by Country: 2021 VS 2025 VS 2032
  50. 5.8.2 Middle East and Africa Inhaler Devices for Respiratory Medicines Sales by Country (2021-2032)
  51. 5.8.3 Middle East and Africa Inhaler Devices for Respiratory Medicines Revenue by Country (2021-2032)
  52. 5.8.4 Egypt
  53. 5.8.5 South Africa
  54. 5.8.6 Israel
  55. 5.8.7 Türkiye
  56. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Inhaler Devices for Respiratory Medicines Sales by Type (2021-2032)
  2. 6.1.1 Global Inhaler Devices for Respiratory Medicines Sales by Type (2021-2032) & (K Units)
  3. 6.1.2 Global Inhaler Devices for Respiratory Medicines Sales Market Share by Type (2021-2032)
  4. 6.2 Global Inhaler Devices for Respiratory Medicines Revenue by Type (2021-2032)
  5. 6.2.1 Global Inhaler Devices for Respiratory Medicines Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Inhaler Devices for Respiratory Medicines Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Inhaler Devices for Respiratory Medicines Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Inhaler Devices for Respiratory Medicines Sales by Application (2021-2032)
  2. 7.1.1 Global Inhaler Devices for Respiratory Medicines Sales by Application (2021-2032) & (K Units)
  3. 7.1.2 Global Inhaler Devices for Respiratory Medicines Sales Market Share by Application (2021-2032)
  4. 7.2 Global Inhaler Devices for Respiratory Medicines Revenue by Application (2021-2032)
  5. 7.2.1 Global Inhaler Devices for Respiratory Medicines Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Inhaler Devices for Respiratory Medicines Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Inhaler Devices for Respiratory Medicines Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Inhaler Devices for Respiratory Medicines Value Chain Analysis
  2. 8.1.1 Inhaler Devices for Respiratory Medicines Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Inhaler Devices for Respiratory Medicines Production Mode & Process
  5. 8.2 Inhaler Devices for Respiratory Medicines Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Inhaler Devices for Respiratory Medicines Distributors
  8. 8.2.3 Inhaler Devices for Respiratory Medicines Customers
9 Global Inhaler Devices for Respiratory Medicines Analyzing Market Dynamics
  1. 9.1 Inhaler Devices for Respiratory Medicines Industry Trends
  2. 9.2 Inhaler Devices for Respiratory Medicines Industry Drivers
  3. 9.3 Inhaler Devices for Respiratory Medicines Industry Opportunities and Challenges
  4. 9.4 Inhaler Devices for Respiratory Medicines Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst